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Abstract
Background: Hair bulge progenitor cells (HBPCs) are multipotent stem cells derived from the bulge region of mice
vibrissal hairs. The purified HBPCs express CD34, K15 and K14 surface markers. It has been reported that HBPCs
could be readily induced to transdifferentiate into adipocytes and osteocytes. However, the ability of HBPCs to
transdifferentiate into cardiomyocytes has not yet been investigated.
Methodology/Principal Findings: The cardiomyogenic potential of HBPCs was investigated using a small cell-
permeable molecule called Cardiogenol C. We established that Cardiogenol C could induce HBPCs to express
transcription factors GATA4, Nkx2.5 and Tbx5, which are early specific markers for pre-cardiomyogenic cells. In
prolonged cultures, the Cardiogenol C-treated HBPCs can also express muscle proteins, cardiac-specific troponin I
and sarcomeric myosin heavy chain. However, we did not observe the ability of these cells to functionally contract.
Hence, we called these cells cardiomyocyte-like cells rather than cardiomyocytes. We tried to remedy this
deficiency by pre-treating HBPCs with Valproic acid first before exposing them to Cardiogenol C. This pretreatment
inhibited, rather than improved, the effectiveness of Cardiogenol C in reprogramming the HBPCs. We used
comparative proteomics to determine how Cardiogenol C worked by identifying proteins that were differentially
expressed. We identified proteins that were involved in promoting cell differentiation, cardiomyocyte development
and for the normal function of striated muscles. From those differentially expressed proteins, we further propose
that Cardiogenol C might exert its effect by activating the Wnt signaling pathway through the suppression of
Kremen1. In addition, by up-regulating the expression of chromatin remodeling proteins, SIK1 and Smarce1 would
initiate cardiac differentiation.
Conclusions/Significance: In conclusion, our CD34
+/K15
+ HBPCs could be induced to transdifferentiate into
cardiomyocyte-like cells using a small molecule called Cardiogenol C. The process involves activation of the Wnt
signaling pathway and altered expression of several key chromatin remodeling proteins. The finding is clinically
significant as HBPCs offer a readily accessible and autologous source of progenitor cells for cell-based therapy of
heart disease, which is one of major killers in developed countries.
Introduction
The hair follicle is a structure that constantly undergoes
cyclic self-renewal of anagen (growth), catagen (regres-
sion) and telogen (resting) stages for the replacement of
natural hair loss [1]. Studies over the past two decades
have been documented the presence of a progenitor cell
population residing in the hair bulge region, near where
the arrector pili muscle attaches to the outer hair root
sheath [2,3]. It was elucidated that hair bulge progenitor
cells (HBPCs) were derived from neural crest cells that
migrated to the bulge during embryonic development
[4,5]. These neural crest cells that are multipotent have
the capability to differentiate into various cell types in
the embryo, including neurons, schwann cells, glial cells,
sensory neurons, melanocytes, endocrine cells, chondro-
cytes and smooth muscles [5-9]. It has been reported
that there are cardiac neural crest-derived cells residing
i nt h eh e a r t ,a sar a r ep o p u l a t i o no fd o r m a n t
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ate into cardiomyocytes when given the appropriate sti-
mulation [10]. However, it would be impractical to
harvest cardiac neural crest cells as a source of progeni-
tor cells for the therapeutic repair of damaged heart tis-
sues. Therefore, it is useful to identify a reservoir of
these progenitor cells, which are abundant and readily
accessible. HBPCs are readily accessible since they reside
on the outer root sheath of the hair follicle and contain
a rich source of neural crest-derived progenitor cells,
but their ability to transdifferentiate into cardiomyocytes
has never been investigated. In this context, it is impor-
tant to establish a method for directing HBPCs to trans-
differentiate into cardiomyocytes. There are several
known chemicals that can induce embryonic and bone
marrow-derived mesenchymal stem cells into cardio-
myocytes-like cells, such as dimethyl sulfoxide and 5-
azacytidine [11-17]. Although the induction mechanisms
are not yet fully understood, it has been reported that
the structure of 5-azacytidine is similar to cytidine. 5-
azacytidine can induce demethylation of cytosine and
activate the expression of myogenic gene MyoD1 which
in turn facilitates the differentiation of bone marrow
stem cells into cardiomyocyte-like cells [16]. Wu et al.
synthesized a novel small molecule from a class of dia-
minopyrimidine compounds, called Cardiogenol C that
could specifically induce embryonic stem cells to differ-
entiate into the cardiomyocytes [18]. They reported that
up to 90% of the Cardiogenol C treated cells positively
expressed GATA4, Mef2 and Nkx2.5, which are essen-
tial transcription factors involved in cardiogenesis. To
date, Cardiogenol C has not been applied to induce
adult stem cells type to differentiate into cardiomyo-
cytes. Moreover, it is still not known how this molecule
works or the proteins that it targets.
In the present study, we first investigated the multipo-
tency of HBPCs and then tested the ability of Cardio-
genol C to induce HBPCs to transdifferentiate into
cardiomyocytes. In addition, we used comparative pro-
teomics to understand how Cardiogenol C worked by
identifying differentially expressed proteins that were
directly or indirectly influenced by Cardiogenol C.
Materials and methods
Ethics Statement
All experimental procedures have been approved by the
animal ethics committee, The Chinese University of
Hong Kong with approval number (09-245) in DH/
HA&P/8/2/1 Pt.7.
Isolation of hair bulge explants
Adult female ICR mice (8-10 weeks old) were sacrificed
by cervical dislocation and anagen staged vibrissal hair
follicles were extracted from the whisker pads according
to methods reported by Sieber-Blum et al. [5]. Briefly,
the whisker pads were isolated and sterilized in 70%
ethanol for 1 min and then washed 3 times in dissecting
medium (DMEM/F12, 0.5% FBS, Invitrogen). Under the
dissecting microscope, the dermis and adipose tissues
were carefully removed from the vibrissal hair follicle
using sharp tungsten needles. The follicle was then cut
at cross-sectioned at levels above the cavernous sinus
and below the attachment for the arrestor pili muscle
(Figure 1B). After the hair bulge region was isolated, it
was then plated onto a collagen-coated 35-mm organ
culture dish containing 0.5 ml culture medium. The cul-
ture medium is composed of the Glasgow Minimal
Essential Medium (GMEM; Sigma-Aldrich, St. Louis,
USA), supplemented with 10% USDA-approved embryo-
nic stem-cell qualified fetal bovine serum (ESQ-FBS,
Invitrogen), and penicillin-streptomycin (0.01 mg/ml).
The explants were maintained in 5% CO2 at 37 °C
inside a humidified cell incubator. The culture medium
was changed every three days.
Production, isolation and purification of CD34
+ HBPCs
After seven days culture, cells have migrated out from
all around the hair bulge explant (Figure 1C). The
explant was then removed using the tungsten needles
and the cells that have attached to the culture plate
were rinsed with PBS and digested with 0.25% trypsin
solution (0.03% EDTA, 10 mM HEPES in Hank’s
balanced salt solution) for 2 min. The reaction was then
Figure 1 Establishment of primary hair bulge cell culture.( A )
Immunohistological staining revealed a large number of CD34
+ cells
(arrows) present in the vicinity of the hair bulge (HB) inferior to
sebaceous glands (SG). (B) Showing an isolated hair follicle from
mouse vibrissal hair. The hair bulge was dissected (extent indicated
by the dotted lines) from the follicle and used for explant culture.
(C) Showing cells that have migrated out from the bulge explant to
form colonies of cells all around the explant. (D) Showing the
appearance of HBPCs following purification with anti-CD34
conjugated magnetic beads.
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pension was further centrifuged at 1,500 rpm for 3 min.
These cells were resuspended and seeded onto two 60-
mm culture dishes in GMEM with 10% ESQ-FBS, 5%
CO2 at 37°C inside the humidified cell incubator. It has
been reported the HBPCs expressed cell surface marker
CD34, therefore we employed Dynal CD34 Progenitor
Cell Selection System (Invitrogen) to select CD34
+
HBPCs out from our cell cultures. Briefly, 4 × 10
7/100
μl of CD34-coated magnetic beads (Dynabeads, Invitro-
gen) were first washed with 1 ml of isolation buffer
(PBS without Ca
2+ and Mg
2+,0 . 1 %B S Aa n d2m M
EDTA, pH 7.4). The tube was placed in a magnetic
stand (Dynal MPC-S Magnetic Particle Concentrator;
Invitrogen) and then the supernatant was aspirated. The
tube was then removed from the magnetic stand, and
the washed magnetic beads resuspended in 100 μlo f
isolation buffer, ready for use. The primary hair bulge
cultures were trypsinized and the cells were suspended
at 1 × 10
8 cells/ml. The appropriated cell density of 1
ml of the crude hair bulge cells suspension was mixed
with 100 μl of pre-washed magnetic beads. The mixture
was then incubated at 4°C for 30 min with gentle tilting
and rotation. The tube was then filled with isolation
buffer (to the level of the magnets) and the cell-bead
complexes were resuspended. The tube was placed in
the magnetic stand for 2 min and then the supernatant
was discarded. The bead-bound cells were washed and
resuspended in 100 μl of isolation buffer. The suspen-
sion was further centrifuged for 10 min at 400 × g to
remove excess detached beads. Finally, the purified
CD34
+ HBPCs pellet was resuspended and cultured in
GMEM plus 10% ESQ-FBS.
Testing the multipotency of the CD34
+ HBPCs
CD34
+ HBPCs were assessed for their ability to transdif-
ferentiate into adipocytes, osteocytes and cardiomyocytes.
Purified HBPCs (1 × 10
5 cells/ml), in normal culture
medium, were plated onto four-well culture plates con-
taining 13-mm glass coverslips. After incubation at 37°C
overnight, the HBPCs were treated with adipogenic indu-
cing medium composing of GMEM, 1 mg/ml insulin
(Sigma-Aldrich), 100 μM dexamethasone (Sigma-
Aldrich), 100 mM 3-isobutyl-1-methylxanthine (Sigma-
Aldrich) and 7.5% ESQ-FBS. After three weeks culture,
the presence of adipocytes was determined using Oil Red
O staining. For osteogenic induction, we used medium
containing GMEM, 10 mM b-glycerophosphate (Sigma-
Aldrich), 50 μM ascorbic acid 2-phosphate, 1 μM dexa-
methasone and 7.5% ESQ-FBS. After 3-weeks culture, the
presence of osteocytes was identified using Alizarin Red
S staining, which detected the presence of mineralized
calcium-deposits. For cardiogenic induction, we used
GMEM plus 5 μM Cardiogenol C (Calbiochem, CA,
USA) and 7.5% ESQ-FBS. The cultures were harvested at
different day-intervals after induction for immunohisto-
chemistry, semi-quantitative RT-PCR analysis, western
blot analysis and comparative proteomic.
Immunohistochemistry
Briefly, Cardiogenol C treated and untreated CD34
+
HBPCs that have been cultured on coverslips were fixed
in 10% formalin overnight. The samples washed 3 times
with PBS and permeabilized with 2 M HCl with 0.5%
(v/v) Triton X-100 for 30 min. These samples were then
blocked with 3% BSA (Amresco) in PBS for 1 hr, and
incubated with primary antibody (1:100) overnight at
room temperature with gentle agitation. Primary antibo-
dies used were mouse monoclonal antibodies against
CD34 (Lab Vision, CA, USA), K14 (Calbiochem, CA,
USA), active b-catenin (Millipore, CA, USA), GATA4
(Santa Cruz Biotechnology, CA, USA), sarcomeric myo-
sin heavy chain (Developmental Studies Hybridoma
Bank, Iowa, IA, USA), Cardiac-specific troponin I (Lab
Vision) and Islet1 (R & D Systems). In addition, rabbit
monoclonal anti-K15 (Epitomics, CA, USA) and goat
polyclonal anti-Nkx-2.5 antibodies (Santa Cruz Biotech-
nology, CA, USA) were also used. The cells were washed
three times with PBST (PBS buffer with 0.05% Tween 20)
for 20 min to remove unbound primary antibody. After-
wards, the appropriate secondary antibody (1:300) was
added for 1 hr at room temperature in the dark with gen-
tle shaking. The secondary antibodies used were FITC-
conjugated donkey anti-mouse immunoglobulin G (IgG)
and Cy2-conjugated donkey anti-goat IgG (Jackson
ImmunoResearch). Unbound secondary antibody was
removed by washing with PBST and then PBS. The sam-
ples were counterstained with the nuclear stained dye
DAPI (Molecular Probes, Eugene, OR, USA) in 50% (v/v)
glycerol and mounted onto slides. The samples were then
examined and recorded under a confocal microscopy
(Confocal Laser Scanning Biological Microscope FV1000;
Olympus, Japan) with fixed exposure settings for all the
samples. Image analysis was performed using a FV10-
ASW software (version 1.6a, Olympus). Three replicates
of each sample were analyzed.
Semi-quantitative RT-PCR analysis
Total RNA was isolated from Cardiogenol C treated and
untreated CD34
+ HBPCs using TRIzol Reagent (Invitro-
gen Life Technologies). First strand cDNA was synthe-
sized using Ready-To-Go You-Prime First-Strand Beads
(GE Healthcare), according to manufacturer’si n s t r u c -
tions. PCR was performed using 1 μl of the synthesized
cDNA as the template, 2.5 μl of 10× PCR buffer (Bio-
Firm, Hong Kong), 1 μl of 50 mM magnesium chloride
solution (Bio-Firm, Hong Kong), 5 μl of 2 mM dNTP
mix (Bio-Firm, Hong Kong), 1 unit of b Taq DNA
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reverse primers (10 μM; 1
st BASE, Singapore), and
DEPC-treated water was added up to a final volume of
25 μl. The primers, listed in Table 1 were designed
using Primer3 software (version 0.4.0, Rozen and Ska-
letsky; http://frodo.wi.mit.edu/ April 13, 2008). The
reaction mixture was then placed in a PTC-100 thermal
cycler with a heated lid (MJ Research, Watertown, MA,
USA) operated under the following amplification condi-
tions: initial denaturation at 95°C for 2 min, followed by
a total of 35 cycles of denaturation at 95°C for 1 min,
annealing at 55°C for 1 min, and extension at 72°C for
1 min. There was a final extension at 72°C for 5 min.
The PCR products were analyzed by 1.5% agarose (USB)
gel electrophoresis and stained with ethidium bromide
(0.5 μg/ml). The expected bands in the gels were
then examined under ultraviolet (UV) light, using a
FluorChem 8000 imaging system (Alpha Innotech, San
Leandro, CA). The intensity of the band for each sample
was normalized using housekeeping b-actin gene. Each
experiment was repeated three times.
Western blot analysis
Briefly, Cardiogenol C treated and untreated of HBPCs
were trypsinized and harvested by centrifugation at
1,500 rpm for 3 min. The protein lysate samples were
then prepared from the cell pellets that were solubilized
in 200 μl of lysis buffer made up of 8 M urea, 2%
CHAPS (Sigma-Aldrich), 2 M thiourea (Sigma-Aldrich),
Table 1 Primers for semi-quantitative RT-PCR analysis
Gene Primer sequences (5’ to 3’) Product
size
(bp)
b-actin Sense 5’-TGT TAC CAA CTG GGA CGA C-3’ 573
Anti-
sense
5’-AAG GAA GGC TGG AAA AGA G-3’
CD34 Sense 5’-TAG CCC AGT CTG AGG TTA GG-3’ 205
Anti-
sense
5’-AGC AGA ACT CCA GAG GTG AC-3’
Dkk1 Sense 5’-TGT CTA GGG GGT CGA ATG TA-3’ 300
Anti-
sense
5’-CAC AGA GCC CCA AAT GTA TC-3’
Etv6 Sense 5’-GTC TCC TTC AGC AGA AAC CA-3’ 424
Anti-
sense
5’-CTG ATC CCA ACT GTG TGT CA-3’
GATA4 Sense 5’-GTG GTG GGT TTT TCT TTG TG-3’ 443
Anti-
sense
5’-CAT AGT CAC CAA GGC TGC TT-3’
Hes6 Sense 5’-AGG GTA GCA GCT TTC AGG AT-3’ 354
Anti-
sense
5’-CCT GAG CTG TCT CCA CCT TA-3’
Keratin 5 Sense 5’-GGA CCA GTC AAC ATC TCT GT-3’ 378
Anti-
sense
5’-TGC CTA AAA GAA GCA GTC TC-3’
Keratin 14 Sense 5’-GAA TGG TTC TTC AGC AAG AC-3’ 386
Anti-
sense
5’-ATG AGG AGA ATT GGG AAG AT-3’
Kremen1 Sense 5’-GCA TCC ATT TCA ACT TCA CC-3’ 431
Anti-
sense
5’-CGT ACA CAG TCC ATC CTT CC-3’
Mthfr Sense 5’-CGT AGA GCA ACT TAG GGA GA-3’ 314
Anti-
sense
5’-CCC ATG AGA AGA ACT AGC AG-3’
Nestin Sense 5’-GAA TCA GAT CGC TCA GAT CC-3’ 487
Anti-
sense
5’-GCA CGA CAC CAG TAG AAC TGG-
3’
Nkx-2.5 Sense 5’-ATC CTA AAC CTG GAG CAG CA-3’ 501
Anti-
sense
5’-AGA TCT TGA CCT GCG TGG AC-3’
Osteocalcin Sense 5’-GCA GCT TGG TGC ACA CCT AG-3’ 405
Anti-
sense
5’-ACC TTA TTG CCC TCC TGC TT-3’
Phc1 Sense 5’-AGC AGA CTT TGC AGA GAA GA-3’ 212
Anti-
sense
5’-TAT ACT GGC TGG GGA TCC TG-3’
Plod2 Sense 5’-GCC AGA AGG TGA GAT TAC TG-3’ 397
Anti-
sense
5’GCA CAA CAG GGT ACT TGT CT-3’
PPAR-g Sense 5’-ACT GTC GGT TTC AGA AGT GC-3’ 258
Anti-
sense
5’-GAT CTC TTG CAC GGC TTC TA-3’
Sik1 Sense 5’-GGA GAG GAA AGG AGA CAC TT-3’ 296
Anti-
sense
5’-GGA TAC TGA GTG CTT GCT TC-3’
Table 1 Primers for semi-quantitative RT-PCR analysis
(Continued)
Sox2 Sense 5’-GCC CTG CAG TAC AAC TCC AT-3’ 363
Anti-
sense
5’-GTC ATT TGC TGT GGG TGA TG-3’
Srms Sense 5’-TCC CTA TGA AGG AAT GAC CA-3’ 354
Anti-
sense
5’-AGC CTG TGT CAG TGA AGG AG-3’
Tbx5 Sense 5’-CAA AGA CAG GTC TTG CGA TT-3’ 426
Anti-
sense
5’-GGT GAG TTT GAG CTT CTG GA-3’
Tcf3 Sense 5’-CTT ATC CCC CAA CTA CGA TG-3’ 315
Anti-
sense
5’-ATA GGA GTC GGG AGG TCT CT-3’
Wnt11 Sense 5’-AGG ATC CCA AGC CAA TAA AC-3’ 330
Anti-
sense
5’-GGA TCC CAC CTT CTC ATT CT-3’
YY1 Sense 5’-GCG GCA AGA AGA GTT ACC TG-3’ 418
Anti-
sense
5’-GGT GTG CAG ATG CTT TCT CA-3’
Ezh2 Sense 5’-AGG CTA ATT GGG ACC AAA AC-3’ 306
Anti-
sense
5’-AAA GCG GTT TTG ACA CTC TG-3’
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P-40 (USB, USA), 0.01% (v/v) TBP, Bezonase
® nuclease
(Novagen, USA) and a cocktail of protease inhibitors
(consisting of leupeptin, pepstatin, aprotinin, PMSF and
EDTA-Na2; Roche Molecular Biochemicals, USA). After
incubation on ice for 2 hr, the cell lysate samples were
centrifuged at 12,000 rpm at 4°C for 15 min. The super-
natant, which contained the proteins, was transferred
into Eppendorf tubes. The concentration of protein for
each sample was determined using a Bio-Rad Protein
Assay Kit. After SDS-PAGE, the proteins were trans-
ferred using a Trans-Blot Semi-Dry Transfer Cell (Bio-
Rad) set at 90 mA for 60 min. The blots were stained
with Ponseau S (Sigma-Aldrich) to confirm the presence
of the proteins. The blots were then blocked with 5%
skimmed milk and 1:1,000 primary antibodies added to
the blots overnight at 4°C with agitation. Primary anti-
bodies used were mouse monoclonal antibodies against
b-catenin (Millipore, CA, USA), Ezh2 (Abnova), Kre-
men1 (Clone 252525, R&D Systems), Phc1 (Abnova)
and tubulin-a (LabVision). The blots were then
washed with TBST (TBS buffer with 0.05% Tween 20)
and probed with the appropriate HRP-conjugated sec-
ondary antibody solution (1:10,000, Zymed), and incu-
bated for 1 hr with gentle agitation. Finally, the blots
were washed and developed using an ECL Western
blotting detection kit (GE Healthcare), according to
manufacturer’s instructions. There were three repli-
cates of each sample. The staining was viewed and
analyzed using a FluorChem 8000 imaging system
(Alpha Innotech Corporation, San Leandro, CA). The
band intensity measurement for each protein band was
recorded and normalized against measurements house-
keeping protein tubulin-a. All procedures were per-
formed in triplicate and results were expressed as the
mean value.
Cell proliferation assay
The effects of Cardiogenol C on HBPCs proliferation
were determined by MTT assay. Briefly, 200 μlo f
CD34
+ HBPCs (1 × 10
4 cells/ml) was seeded into a
96-well plate. The cells were allowed to adhere and
then treated with Cardiogenol C. At set time intervals
between 1-5 days, 20 μl of 12 mM 3-(4,5-dimethylthia-
zol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT)
solution in medium without the phenol red was added
to the cultures and incubated for 4 hr at 37°C. The
supernatants were then discarded and 200 μlo fD M S O
solution was added. The plates were placed on an orbi-
tal shaker for 15 min to dissolve formazan crystals and
then measured on a microplate reader (Bio-Rad) set at
490 nm. There were three replicates for each time
point analyzed.
Scanning electron microscopy
Briefly, treated and untreated HBPCs cultured on cover-
slips were washed with PBS and fixed in 2.5% glutaral-
dehyde dissolved in 0.1 M freshly prepared Sorensen’s
Phosphate Buffer (PB, pH 7.4) for 4 hr. The samples
were post-fixed with 1% aqueous osmium tetraoxide for
15 min and washed 3 times in PB for 10 min. The sam-
ples were then dehydrated through a graded series of
ethanol, critical point dried and coated with palladium-
gold. The coated specimens were examined under a
JSM-6301F scanning electron microscope (Joel, Tokyo,
Japan).
Transmission electron microscopy
The treated and untreated HBPCs were fixed in freshly
prepared 2.5% glutaraldehyde in 0.1 M phosphate buffer
(pH 7.4) for 4 h. After rinsing in phosphate buffer, the
cells were post-fixed in 1% osmium tetraoxide for
30 min. The cultures were then washed with MilliQ-
water, dehydrated through a graded series of ethanol,
cleared in propylene oxide, and then embedded in Epon
812 embedding resin. The embedded cultures were sec-
tioned with an UltraCut R microtome (Leica, Austria),
double-stained with uranyl acetate and lead citrate, and
then examined using a transmission electron microscope
(Hitachi H-7100FA, Hitachi, Tokyo, Japan).
Proteomics: sample preparations for two dimensional gel
electrophoresis (2-DE)
Comparative proteomic analysis was performed as we
previously reported [19,20]. Briefly, 100 μg of total pro-
teins from Cardiogenol C treated and untreated CD34
+
HBPCs were used in each 2-DE. The samples were first
washed in ice-cold saline and then lyzed in the presence
of 7 M Urea, 2 M thiourea, 0.01% TBP, 4% CHAP,
0.01% NP 40 and a mixture of protease inhibitors
(Roche Molecular Biochemicals, Mannheim, Germany).
After 2 hr incubation at 4°C, the supernatants were
harvested by centrifugation at 13,000 rpm for 15 min.
The total protein concentration of the samples was
determined using a protein assay kit (Bio-Rad, Hercules,
USA).
Proteomics: two dimensional gel electrophoresis
First dimensional separation of the proteins was per-
formed on an IPGphor IEF system using immobiline pH
4 - 7 dry IPG strips (GE Healthcare, Uppsala, Sweden).
The cell lysates (100 μg) were loaded onto rehydrated
immobiline strips. The setting for step 1 was 500 volts
for 500 vhr; step 2 was 1000 volts for 1000 vhr; step
3 at 2000 volts for 2000 vhr; step 4 at 3000 volts for
3000 vhr; step 5 at 4000 volts for 4000 vhr; step 6 at
5000 volts for 5000 vhr and finally, step 7 at 5600 volts
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crylamide gel electrophoresis (SDS-PAGE) was used for
the second dimension, using 10% polyacrylamide slab
gels (18 × 16 cm). Briefly, the gel strips were removed
from the IPGphor IEF system and equilibrated for 30
min in 6 M urea, 30% w/v glycerol, 2% w/v SDS, 0.05 M
Tris-HCl, pH 6.8 with 2% w/v DTT. They were then
treated with 2% iodoacetamide for 30 min. The gel
strips were embedded on the cathode side of a pre-pre-
pared SDS-PAGE gel and 0.2% agarose was poured into
the cathode side to seal the gel strip. The second dimen-
sion electrophoresis was performed in an ISO-DALT
apparatus (Hoefer Scientific Instruments, San Francisco,
USA). A tris-tricine dissociating buffer system was used
and the gel was run at 60 mA constant current over-
night. The gels were then fixed in 40% methanol con-
taining 10% acetic acid for 1 hr and followed by a
second fixative containing 50% ethanol. The fixed gels
were further sensitized with 0.02% sodium thiosulphate
for 10 min. After sensitization, the gels were stained
with silver nitrate (Sigma-Aldrich Co., St Louis, USA)
and developed. The molecular mass of the protein spots
was determined by co-running the samples with stan-
dard protein markers, covering the range of 14.4 - 116
kDa (Fermanta International Inc, Burlington, Canada).
The pI values were determined according to the infor-
mation provided by the supplier of the IPG strips. The
silver stained 2-DE gels of Cardiogenol C treated and
untreated HBPCs were scanned using an Agfa DUOS-
CAN densitometer. The distribution of the protein spots
in the 2-DE gels was recorded, compared and quantified
using the ImageMaster 2 D Elite software (Amersham
Biosciences, Freiburg, Germany). The data were normal-
ized with respect to the total density of the gel image.
Three replicates of each sample were analyzed.
Proteomics: in-gel digestion and MALDI-TOF analysis
Protein spots were isolated from the silver stained gels
using a spot picker (EXQuest™ Spot Cutter). Each iso-
lated spot was destained in 500 μl of 15 mM potassium
ferricyanide and 50 mM sodium thiosulfate for 10 min.
The sample was then further washed 3 times for 15 min
each in 500 μl of 50% acetonitrile/25 mM NH4 bicarbo-
nate at pH 8.0. The spot was soaked in 100% acetoni-
trile for 5 min to dehydrate the gel, the acetonitrile was
removed when the gel turned opaque white and the gel
was finally dried in a Speed-Vac Evaporator (UniEquip,
Martinsried, Germany). For enzyme digestion, the gel
spot was rehydrated in cold trypsin (15 μg/mL, Pro-
m e g a ,M a d i s o n )m a d eu pi n2 5m Ma m m o n i u mb i c a r -
bonate, pH 8.0. After the gel had swelled and cleared, it
was incubated at 37°C for 16 - 24 h. The peptide was
then extracted using 50% acetonitrile and 5% trifluoroa-
cetic acid. The extract peptides (0.5 μl) were then mixed
with 1 μl of fresh cyano-matrix solution (consisting of
an 8 mg a-cyano-4-hydroxycinnamic acid in 50% aceto-
nitrile/0.1% TFA) on a MALDI plate. The protein sam-
ple was analyzed in a time-of-flight mass spectrometer
(Voyager-DE™PRO Biospectrometry™, Applied Biosys-
tems) using an accelerating voltage of 20 kV. For data-
base search, known contamination peaks such as
autoproteolysis and keratin were extracted prior to a
protein mass fingerprint search with MASCOT software
(Matrix Science, London, UK) in CBInr database. Up to
one missed tryptic cleavage was considered and a mass
accuracy of 100 ppm was used for all tryptic-mass
searches. Protein identification was confirmed by using
MS-Fit software http://prospector.ucsf.edu.
Results
Isolation and Purification of CD34
+ HBPCs
It has been reported that cell surface marker CD34 is
specifically expressed by HBPCs isolated from the hair
mouse bulge [21]. We performed immunohistological
staining to determine where CD34
+ cells were normally
distributed in the vibrissa. CD34
+ HBPCs were evident
in the bulge region of the outer root hair sheath, inferior
to the sebaceous glands (Figure 1A). We carefully
microdissected and isolated the bulge area from the
vibrissa follicles and explanted them onto organ culture
dishes (Figure 1B). We observed cells migrating out
from the bulge explants after seven days culture. Colo-
nies of cells were found grown around the bulge region
(Figure 1C) which were trypsinized and seeded onto the
60 mm plate (Figure 1D). The cells from the primary
hair bulge culture was then harvested and purified using
magnetic beads coated with CD34 monoclonal antibody.
We also confirmed that these cells expressed other
HBPC cell surface markers K15 and K14 (Figure 2A, B).
Moreover, semi-quantitative RT-PCR revealed that these
Figure 2 Characterization of CD34
+ HBPCs. (A-B) Immuno-
fluorescent staining showed HBPCs specifically expressed
established HBPCs surface markers Keratin 14 (K14) and 15 (K15). (C)
Semi-quantitative RT-PCR analysis confirmed that the HBPCs
expressed K14. In addition, HBPCs also expressed K5 and Snail and
Sox2. (D) In contrast, dermal fibroblasts (DFs) isolated from adjacent
to the hair bulge did not express K14 and K5. b-actin served as an
internal control.
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(Figure 2C). Dermal fibroblasts, isolated from adjacent
to the hair bulge, did not express any of the HBPC sur-
face markers (Figure 2D). This confirms that our
HBPCs were derived from cells that have migrated out
from bulge explants and not from connective tissue cells
that have contaminated the bulge explants during
isolation.
Establishing the multipotency of CD34
+ HBPCs
The multipotency of HBPCs was assessed for their abil-
ity to transdifferentiate into adipocytes and osteocytes.
The HBPCs were cultured in the presence of adipogenic
or osteogenic-inducing media. We established that the
HBPCs could be readily induced to differentiate into
adipocytes after culturing 21 days that they were posi-
tively stained with Oil Red O solution (Figure 3A).
Under scanning electron microscopy, the cytoplasm of
induced HBPCs clearly show the presence of empty
vacuoles which originally contained storage of lipids
(Figure 3B). Semi-quantitative RT-PCR analysis revealed
that, following adipogenic-inducing medium treatment,
CD34 and Nestin (HBPC markers) were down-regulated
whereas PPAR-g (adipocyte marker) expression was up-
regulated (Figure 3C). Similarly, HBPCs could be
induced to transdifferentiate into osteocytes by osteo-
genic-inducing medium (Figure 3D). Transmission elec-
tron microscopy revealed that the induced HBPCs could
secrete bone matrix-like materials into the interstitial
space (Figure 3E). Semi-quantitative RT-PCR analysis
showed that CD34 and Nestin expression were down-
regulated while osteocalcin (osteocyte marker) expres-
sion was up-regulated (Figure 2F).
We also investigated the ability of HBPCs to transdif-
ferentiate into cardiomyocytes using small molecule, Car-
diogenol C. Semi-quantitative RT-PCR analysis revealed
that Cardiogenol C could activate the expression of tran-
scription factors GATA4, Tbx5 and homeodomain pro-
tein Nkx2.5, which are all early pre-cardiac cell markers
that are indispensible for initiating cardiomyogenesis
(Figure 4A). Immunofluorescent staining further con-
firmed that Cardiogenol C induced expressions of cardiac
marker Nkx2.5 (Figure 4B) and GATA4 (Figure 5A-D).
In addition, western blot analysis revealed that GATA4
expression was initiated from day 4 culture onwards in
Cardiogenol C-treated HBPCs (Figure 5E). Immunofluor-
escent staining showed the Cardiogenol C-treated
HBPCs also progressively expressed Cardiac-specific tro-
ponin I (Figure 6E-H) and sarcomeric myosin heavy
chain proteins (Figure 6I-L). However, we did not
observe any contracting cells in the cardiogenol C-treated
cultures. In this context, we called these cells cardiomyo-
cyte-like cells rather than cardiomyocytes. Huangfu et al.
reported that treating fibroblasts with Valproic acid, a
histone deacetylase inhibitor, enabled the fibroblasts to
be more efficiently reprogrammed to become induced
pluripotent stem cells [22]. Hence, we treated our HBPCs
simultaneously with Valproic acid and Cardiogenol
C. The mixture did not improve cardiomyocyte transdif-
ferentiation. In fact, the presence of Valporic acid inhib-
ited the process (Figure 6M-T). We also investigated the
effects of Cardiogenol C on cell division. MTT assay
Figure 3 Developmental potential of HBPCs. (A) Adipogenic
potential of HBPCs was examined. Oil Red O dye staining revealed
the presence of adipocytes (arrows) in the HBPC cultures, 3 weeks
after adipogenic-inducing medium treatment. Approximately 27 ±
3% of the induced cells were adipocytes. (B) Scanning electron
micrograph showing a representative adipocyte that have formed in
the cultures. The cytoplasm of these cells was filled with numerous
small lipid vesicles (arrows). (C) Semi-quantitative RT-PCR analysis
revealed that after the HBPCs were incubated with adipogenic-
inducing medium for 3 weeks, CD34 and Nestin (HBPC marker)
expression were inhibited while PPAR-g (adipocyte marker)
expression was induced. b-actin served as an internal control. (D)
Osteogenic potential of HBPCs was also examined. Alizarin Red S
staining revealed the presence of osteocytes (arrows) in the
cultures, after 3 weeks osteogenic-inducing medium induction.
Approximately 31 ± 3% of the treated cells have transdifferentiated
into osteocytes (arrows). (E) Transmission electron micrograph
showing a representative osteocyte that has transdifferentiated from
the HBPCs. These cells were capable of secreting bone matrix
(arrows). (F) Semi-quantitative RT-PCR analysis revealed that after
HBPCs were incubated in osteogenic-inducing medium for 3 weeks,
CD34 and Nestin expressions were inhibited while Osteocalcin
(bone marker) was activated. b-actin served as an internal control.
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proliferation (Figure 7).
Comparative proteomic analysis
We used comparative proteomics to elucidate how
Cardiogenol C was able to induce HBPCs to become
cardiomyocyte-like cells. Two-dimensional gel electro-
phoresis was performed and the protein profile of
HBPCs treated with Cardiogenol C for four days
was compared with untreated HBPCs. We identified
18 silver-stained protein spots that were differentially
expressed from 3 independent experiments. Twelve of
the proteins were up-regulated by Cardiogenol C treat-
m e n t( F i g u r e8 ) ,w h i l e6o ft h ep r o t e i n sw e r ed o w n -
regulated (Figure 9). MALDI-TOF MS analysis revealed
that the up-regulated proteins included: 1) COP9 sig-
nalosome complex subunit 6, 2) emerin, 3) methylene-
tetrahydrofolate reductase (Mthfr), 4) myosin light
polypeptide 3, 5) myosin light polypeptide 6, 6) procol-
lagen-lysine, 2-oxoglutarate 5-dioxygenase 2 precursor
(Plod2), 7) protein C-ets-1, 8) salt-inducible kinase 1
(SIK1), 9) SWI/SNF related protein Smarce1, 10) tran-
scription cofactor HES-6, 11) tripartite motif-contain-
ing protein 54, and 12) troponin C (summarized in
Table 2). The down-regulated proteins were included:
1) cell division protein kinase 6 (Cdk6), 2) growth/dif-
ferentiation factor 8 precursor (GDF-8), 3) Kremen
protein 1 precursor (Kremen1), 4) tight junction pro-
tein ZO-1, 5) transcription factor ETV6, and 6) Tyro-
sine protein kinase Srms. The observed pI and
molecular mass of each proteins identified on the 2DE
gel matched closely with the theoretical values pro-
vided in the bioinformatic database. Their functions
were also summarized in the Table 2 and 3.
We next performed semi-quantitative RT-PCR analysis
to determine whether some of the differentially-expressed
proteins identified were also affected at the transcriptional
level. We established that Hes6, Mthfr, Plod2 and SIK1
transcriptions were up-regulated following Cardiogenol C
treatment (Figure 10A); whereas, ETV6, GDF-8, Kremen1
a n dS r m st r a n s c r i p t i o n sw e r ed o w n - r e g u l a t e d( F i g u r e
10B). These results were the same as those observed in the
compare proteomic analyses.
Cardiogenol C activates Wnt/beta-catenin signaling
Kremen1 was one of the proteins found down-regu-
lated in our comparative proteomic analysis. This pro-
tein normally acts as a receptor for Dickkopf (DKK)
protein and both cooperate together to block Wnt/b-
catenin signaling [23,24]. Hence, we decided to investi-
gate whether the presence of Cardiogenol C could acti-
vate the Wnt/b-catenin pathway. Western blot analyses
revealed that there were significant increase in the Kre-
men1 and b-catenin following Cardiogenol C treatment
(Figure 11A). It has been reported that Wnt-11 is one
of the potential activator of the Wnt/b-catenin signal-
ing during cardiogenesis [25]. Transcriptional factor,
Lef1, participates in Wnt/b-catenin signaling by med-
iating in the phosphorylation of b-catenin [26]. We
established that Dkk1 and Kremen1 expression were
down-regulated; whereas, Lef1 and Wnt11 expression
were up-regulated by semi-quantitative RT-PCR analy-
sis (Figure 11B). Immunofluorescent staining revealed
that b-catenin was detected in the cytoplasm and
nucleus of Cardiogenol C-treated HBPCs at Day 3 but
not in untreated cultures (Figure 12A-B). Recently,
Islet1 has been reported to be a downstream target of
b-catenin in cardiac progenitor cells [27]. Therefore,
we examined whether Cardiogenol C could induce
HBPCs to express Islet1. We established that the Car-
diogenol C-treated cells expressed Islet1 after 3 days
culture (Figure 12C-D).
Cardiogenol C suppresses genes involved in chromatin
remodeling
S I K 1w a sa l s oo n eo ft h ep r o t e i n st h a tw ef o u n du p -
regulated in the comparative proteomic analysis. SIK1
has been identified as a class II Histone deactylases
(HDACs) kinase that is specifically expressed in the
Figure 4 Cardiomyogenic induction of HBPCs by Cardiogenol
C. (A) Semi-quantitative RT-PCR analysis revealed that Cardiogenol C
could induce HBPCs to express cardiac-specific markers GATA4, Tbx5
and Nkx2.5. b-actin served as an internal control. (B-C)
Immunofluorescent staining showed HBPCs expressed myogenic
transcription factor Nkx2.5 (white arrows) following 5 μM
Cardiogenol C treatment for 4 days. In contrast, the untreated
samples were negatively stained.
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phorylate cytoplasmic class II HDACs to trigger their
translocation into the nucleus and activate MEF2-
dependent transcription [28,29]. This suggests that
chromatin remodeling is also involved in Cardiogenol
C-induced cardiogenesis. Recent studies revealed that
the Polycomb gene complex may competitively antago-
nize nucleosome remodeling by the SWI/SNF-family
complex [30]. Hence, we examined the effects of
Cardiogenol C on the polycomb group gene complex.
Semi-quantitative RT-PCR analysis revealed that poly-
homeotic-like 1 (Phc1), Zeste homolog 2 (Ezh2) and
transcription factor YY1 expression were significantly
down-regulated following Cardiogenol C treatment (Fig-
ure 13A). Moreover, western blot analysis confirmed
that Phc1 and Ezh2 expressions were inhibited by Car-
diogenol C (Figure 13B-C).
Discussion
Previous studies on HBPCs have mostly been related to
hair regeneration and re-epithelialisation of burn
wound, chronic wound and ulcerated skins [4,31-34]. In
the present study, we have demonstrated that the
HBPCs, isolated from mouse vibrissa, are multipotent
a n dc a np o t e n t i a l l yp r o v i d eas o u r c eo fa u t o l o g o u sp r o -
genitor cells for cardiac repair. These HBPCs expressed
K15, a specific marker for hair bulge stem cells, and also
expressed neural crest stem cell markers Nestin and
Snail [32]. Furthermore, these cells expressed cell sur-
face markers K5, K14 and CD34 which confirm these
cells were originated from the bulge region and not
from adjacent connective tissue which do not express
these markers [35]. Our HBPCs also expressed Sox2
which is a key transcription factor involved in maintain-
ing pluripotency and self-renewal in embryonic stem
cells [36-38]. Since HBPCs express the pluripotent mar-
ker Sox2, we investigated the developmental potential of
these cells. These cells were able to transdifferentiate
into adipocytes and osteocytes when chemically induced.
To investigate the ability of HBPCs to transdifferentiate
into cardiac cells, we used a small cell permeable mole-
cule called Cardiogenol C. This molecule was first
reported to be able to induce embryonic stem cells to
differentiate into beating cardiomyocytes [18]. We found
that Cardiogenol C-treated HBPCs can be induced to
express Nkx2.5 and GATA4, two early markers for pre-
cardiac cells [39]. These genes are evolutionary highly
conserved and indispensable for normal heart develop-
ment [39,40]. In mature Cardiogenol C-treated cultures,
we established that the cells can also express cardiac-
specific troponin I and sarcomeric myosin heavy chain.
In contrast to findings reported by Wu et al., who
observed beating cardiomyocytes following Cardiogenol
C-treated of embryonic stem cells, we could not find
cardiomyocytes capable of contracting in our Cardio-
genol C-treated HBPCs [18]. In this context, Cardio-
genol C cannot be used to produce fully functional
cardiomyocytes by HBPCs - despite its ability to induce
expression of key cardiac transcriptional factors Nkx2.5,
GATA4, Tbx5 and Islet1.
Recently, Huangfu et al. revealed that Valporic acid (a
histone deacetylase inhibitor) could be used to enhance
the reprogramming of somatic cells into induced pluri-
potent stem cells by more than 100-fold [41]. We there-
fore decided to use Valporic acid, in combination with
our Cardiogenol C, to induce a more comprehensive
transdifferentiation of our HBPCs - producing cardio-
mycytes that were capable of spontaneous contraction.
However, we found that the HBPCs were not responsive
to the Valporic acid treatment. Our results imply that
HBPCs are only capable of transdifferenting into cardio-
myocyte-like cells when induced by Cardiogenol C. We
believe that this limited response may be attributed to
the developmental plasticity of our HBPCs verses
embryonic stem cells (i.e. multipotent verses pluripotent,
respectively). Liu et al. recently reported that hair follicle
stem cells from the bulge region could differentiate into
Figure 5 Cardiogenol C induces HBPCs to express GATA4.
Immunofluorescent staining (A-D) and semi-quantitative RT-PCR
analysis (E) revealed that HBPCs began expressing GATA4 (arrows) 4
days after Cardiogenol C treatment.
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promoter [42]. In this study, our isolated CD34
+ HBPCs
behave like mesenchymal stem cells capable of differen-
tiating into various mesenchymal lineages, such as
adipocytes and osteocytes. Though HBPCs can only
transdifferentiate into cardiomyocyte-like cells, they may
still be potentially useful once a method for stimulating
these cells to contract has been established.
In this study, we used comparative proteomic approach
to elucidate how Cardiogenol C was able to induce HBPCs
to transdifferentiate into cardiomyocyte-like cells. We
found a number of differentially expressed proteins in our
treated HBPCs. Kremen1 expression was significantly
down-regulated in the Cardiogenol C-treated cells. It has
been reported that Kremen1 and Kremen2 are two dick-
kopf homolog 1 (DKK1) transmembrane receptors which
regulate the canonical Wnt/b-catenin signaling pathway.
Figure 6 Effects of Valproic acid on cardiomyogenic induction by Cardiogenol C. Cardiogenol C-treated and untreated HBPCs were stained
with Cardiac Specific Troponin I and sarcomeric myosin heavy chain (MF20) antibodies. The results revealed that Cardiogenol C-treated HBPCs
expressed cardiac specific troponin I (G-H) and sarcomeric myosin heavy chain (J-L) progressively. HBPCs treated with Valproic acid alone (M-P)
or Valproic acid plus Cardiogenol C (Q-T) did not induce GATA4 or cardiac specific troponin I expressions (M-T).
Figure 7 Effects of Cardiogenol C on HBPCs proliferation.M T T
assay showed that Cardiogenol C treatment significantly inhibited
HBPCs proliferation.
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Page 10 of 16Figure 8 Comparative proteomic analysis: Identification of protein up-regulated by Cardiogenol C. The silver stained 2-DE gel showing
proteins differentially up-regulated in HBPCs by Cardiogenol C.
Figure 9 Comparative proteomic analysis: Identification of protein down-regulated by Cardiogenol C. The silver stained 2-DE gel
showing proteins differentially down-regulated in HBPCs by Cardiogenol C.
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the canonical Wnt/b-catenin signaling by blocking Wnt
co-receptors LRP5/6 [23,24]. Both canonical and nonca-
noncial Wnt signaling pathways are essential regulators
for coordinating cardiac specification and morphogenesis.
Canonical Wnt/b-catenin signaling regulates early car-
diogenesis by enhancing the proliferation of cardiac pro-
genitors and differentiation of cardiomyocytes [43,44].
b-catenin is thought to interact with members of the
LEF-1/TCF family of transcription factors to mediate in














41/5.4 35.9/5.5 O88545 1.7 A complex involved in various cellular and developmental
processes. It is an essential regulator of the ubiquitin conjugation
pathway
Emerin 27/4.6 29.4/4.9 O08579 2.3 Emerin may be required for the stability and normal function of
rigorously moving nuclei in skeletal muscle and heart
Methylenetetrahydro folate
reductase (Mthfr)
70/4.9 74.7/5.2 Q9WU20 2.4 Folate is important for normal heart development. It is a key
enzyme in folate and homocysteine metabolism
Myosin light polypeptide 6 14/4.7 16.8/4.6 Q60605 1.4 Regulatory light chain of myosin
Myosin light polypeptide 3 19/4.9 21.8/5.0 P08590 1.6 Regulatory light chain of myosin
Procollagen-lysine,2-
oxoglutarate 5- dioxygenase 2
precursor (Plod2)
80/6.5 84.5/6.3 Q9R0B9 4.0 Essential for the stability of the intermolecular collagen cross-
links; highly expressed in heart, lung, kidney, eye, ovary, and
placenta
Protein C-ets-1 55/4.8 50.2/5.0 P27577 1.7 Transcription factor. Binds to DAXX. Interacts with UBE2I.
Essential for normal coronary and myocardial development in
chicken embryos
Salt-inducible kinase (SIK1) 81/6.4 85.0/6.4 Q60670 3.8 Transient role during the earliest stages of myocardial cell
differentiation and/or primitive chamber formation and may also
be important for the earliest stages of skeletal muscle growth
and/or differentiation. Potential role in G2/M cell cycle regulation
SWI/SNF related protein
Smarce1
49/4.5 46.6/4.9 O54941 1.9 Involved in transcriptional activation and repression of select
genes by chromatin remodeling (alteration of DNA-nucleosome
topology)




36/5. 40.3/5.1 Q9BYV2 1.6 It may bind and stabilize microtubule during myotube formation
Troponin C 17/4.2 18.4/4.0 P19123 1.4 Troponin is the central regulatory protein of striated muscle
contraction. The binding of calcium to Tn-C abolishes the
inhibitory action of Tn on actin filaments


























130/6.4 194.7/6.2 P39447 1.4 The N-terminal may be involved in transducing a signal required for tight
junction assembly, while the C-terminal may have specific properties of




60/6.5 56.4/6.8 P97360 3.6 Transcription repressor; binds to the DNA sequence 5’ CCGGAAGT-3’
Tyrosine protein
kinase Srms
56/6.6 55.8/6.7 Q62270 1.5 May be involved in proliferation or differentiation of keratinocytes in the
skin
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Page 12 of 16Wnt signaling [26]. b-catenin also modulates the
expression of Islet1 in cardiac progenitor cells which is
required for cardiogenesis [27]. The noncanonical Wnt
signaling pathway, which is independent of b-catenins,
involves protein kinase C and Jun amino-terminal
kinase also regulates cardiac differentiation [45]. Wnt11
in the noncanonical pathway was reported to enhance
cardiomyocytes differentiation in various stem cell
populations [25,46,47]. In our semi-quantitative RT-
PCR studies, we found Lef1 and Wnt11 expression were
up-regulated by Cardiogenol C. Furthermore, our
immunofluorescent staining results revealed that b-
catenin was present in both the nucleus and cytoplasm.
Therefore, it appears that Cardiogenol C could activate
Wnt/b-catenin signaling to induce cardiogenesis. The
results of our MTT cell proliferation assay confirmed
that Cardiogenol C-treatment significantly decreased
HBPCs proliferation. Nevertheless, we cannot explain
why Cardiogenol C induced an increase in b-catenin yet
a decrease in cell proliferation, as activation of the Wnt
signaling pathway is normally associated with increased
cell proliferation. This paradox may be required to be
investigated in the future.
Besides cardiac-inducing transcription factors, epige-
netic factors may also play a contributory role in cardio-
myocyte differentiation. This idea is supported by
reported findings that 5-azacytidine, an unspecific DNA
methyltransferase inhibitor, can induce cardiogenesis
[48]. This reagent prevents methylation at cytosine,
which makes CpG islands in the promoter sequen-
ces of genes involved in cardiac differentiation. The
unmethylated sequence allows the binding of transcrip-
tion initiation machinery. Moreover, several chromatin
remodeling proteins, such as methyltransferase Smyd1,
SWI/SNF protein Baf60c, HDAC5 and HDAC9, have
also been implemented in cardiomyocytes differentiation
[49-51]. In this context, we identified two chromatin
remodeling proteins, SIK1 and Smarce1, which were up-
regulated by Cardiogenol C in our comparative proteo-
mic analysis. SIK1 is a kinase of class II HDACs. It stimu-
lates cardiac-specific transcription factor Mef2 via
phosphorylation of HDACs [29]. Smarce1 is a compo-
nent of the SWI/SNF complex. It can interact specifically
with transcription factor REST to repress neuronal genes.
Therefore, up-regulation of Smarce1 might facilitate
the repression of neuronal- and neural crest-related
genes (e.g. Nestin and Snail) in our Cardiogenol C-trea-
ted HBPCs. Recently, the polycomb group complex
proteins have been identified as essential in the mainte-
nance of embryonic and adult stem cells, by silencing
genes that are necessary for stem/progenitor cells to dif-
ferentiate into various tissue types [52-54]. Therefore,
we examined whether the polycomb group proteins
were also involved in cardiac differentiation induced by
Cardiogenol C. We found that Cardiogenol C sup-
pressed Phc1, Ezh2 as well as YY1 expression. Ezh2 con-
tains SET domain and belongs to polycomb repressor
complex 2; while Phc1 and YY1 contain zinc-finger
domain and are components of PRC1 maintenance
Figure 10 RT-PCR analysis of differentially expressed proteins.
Semi-quantitative RT-PCR analysis was performed to confirm that
some of differentially expressed proteins identified in the
comparative proteomics were also differentially transcribed. (A) The
transcription levels of Hes6, Mthfr, Plod2 and SIK1 were found up-
regulated in the Cardiogenol C-treated samples. (B) ETV6, GDF-8,
Kremen1 and Srms expression were down-regulated by Cardiogenol
C. b-actin served as an internal control.
Figure 11 Activation of Wnt signaling pathway following
Cardiogenol C induction. (A) Western blot analysis revealed that
Kremen1 was down-regulated in Cardiogenol C-treated HBPCs.
Tubulin served as an internal control. (B) Semi-quantitative RT-PCR
analysis revealed Dkk1 and Kremen1, which are normally involved in
the Wnt signaling pathway, were down-regulated in Cardiogenol C-
treated HBPCs while Lef1 and Wnt11 expression were up-regulated.
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Page 13 of 16complex [54,55]. These findings lead us to speculate that
up-regulation of SIK1 as well as down-regulation
of polycomb group proteins may silence genes that
normally represses cardiac differentiation.
We have also identified several more proteins that
were down-regulated by Cardiogenol C. Cdk6 was
inhibited by Cardiogenol C. This protein is a vertebrate
cdc-2 related kinase. It interacts with the G-type cyclins
in the early G1 phase and functions as a retinoblastoma
protein (Rb) kinase that phosphorylates the Rb protein.
Phosphorylated Rb releases its binding partner tran-
scription activator E2F. The free E2F in turn stimulates
the transcription of genes essential for DNA replication,
which initiates the cell cycle into the S phase [56].
Indeed, it has also been reported that cdk6 expression
must be suppressed in order to allow proper osteoblasts
and osteoclasts differentiation [55,57,58]. Therefore, it
would be expected that mitogenic cdk6 expression
w o u l db ei n h i b i t e ds ot h a tt h eH B P C sc o u l de x i tt h e
cell cycle to initiate differentiation. Myostatin (also
known as GDF-8) expression was also suppressed in
response to Cardiogenol C treatment. Morissette et al.
reported that myostatin was a negative regulator
involved in controlling the growth of striated muscles in
the heart [59]. Therefore, it was not surprising to
observe the decreased myostatin expression when
Figure 12 b-catenin and Islet1 expression in HBPCs after
Cardiogenol C treatment. (A-B) Immunofluorescent staining
revealed the presence of the b-catenin (white arrows) in the
Cardiogenol C-treated HBPCs but not in the untreated HBPCs.
(C-D). Immunofluorescent staining revealed HBPCs expressed
Islet1 (white arrows) following Cardiogenol C-treatment but not
in the untreated cells.
Figure 13 Cardiogenol C inhibits chromatin remodeling gene expression in HBPCs. (A) Semi-quantitative RT-PCR analysis of three
components of the polycomb gene complex (Phc1, Ezh2 and YY1). Expressions of all three genes were down-regulated in HBPCs following
Cardiogenol C-treatment. The bar chart showed the normalized density measurements of the PCR bands. (B and C) Western blot analyses
confirmed that Cardiogenol C inhibited Phc1and Ezh2 expressions in HBPCs. a-tubulin served as an internal control. The bar charts showed the
normalized density measurements of the protein bands. The experiments were performed in triplicates, and each data point was expressed as
mean value ± SEM. *Statistically significant difference (p < 0.05).
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Page 14 of 16Cardiogenol C-treated HBPCs transdifferentiate into
cardiomyocyte-like cells.
In conclusion, we demonstrated for the first time that
HBPCs can be induced to transdifferentiate into cardi-
omyocyte-like cells using Cardiogenol C. With more
research into understanding the developmental proper-
ties of HBPCs, these readily accessible cells may in the
future provide an abundant potential source of pro-
genitor cells for the therapeutic treatment of heart
diseases.
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